文献速递重症综合管理与镇静镇痛心脑血管急症

他们有选择吗?严重急性脑损伤后的代理决策

Do They Have a Choice? Surrogate Decision-Making After Severe Acute Brain Injury.
PubMed 文献 · Crit Care Med · 2023-03-27
一句话结论并非所有代理决策者都认为自己正在做决定,几乎所有代理决策者都难以应对预后不确定性。

该研究为一项大型前瞻性纵向队列研究(n=222)的一部分,在患者因严重急性脑损伤(SABI)急性住院期间对代理决策者进行半结构化访谈,采用建构主义扎根理论分析,共访谈19例患者的22名代理决策者。患者年龄20至79岁(均值55岁),主要诊断包括卒中(n=13;68%)、创伤性脑损伤(n=5;26%)及心脏骤停后缺氧性脑损伤(n=1;5%);患者以男性为主(n=12;63%),代理决策者以女性为主(n=13;68%)。分析发现两种决策视角:一组代理决策者感到明确的决策主体感,另一组则报告更被动的角色,甚至不认为存在需要做的决定;两组均将预后不确定性视为SABI的核心挑战,但应对方式不同,仅主动决策的代理决策者认为限时试验有帮助。作者认为需要针对代理决策者当前决策视角的纵向预后沟通策略。

要点

  • SABI急性期代理决策者存在两种视角:一组有明确决策主体感,另一组被动、甚至不认为存在决策。
  • 两组代理决策者均将预后不确定性视为SABI的核心挑战,但管理方式不同。
  • 仅感到自己在主动决策的代理决策者认为限时试验有帮助。
  • 研究共访谈19例患者的22名代理决策者,患者年龄20至79岁(均值55岁)。
  • 作者认为需要针对代理决策者当前决策视角的纵向预后沟通策略。

适用人群与场景

  • 患者因严重急性脑损伤(SABI)急性住院期间的代理决策者;患者年龄20至79岁(均值55岁)。
  • 患者主要诊断:卒中(n=13;68%)、创伤性脑损伤(n=5;26%)、心脏骤停后缺氧性脑损伤(n=1;5%)。
  • 患者以男性为主(n=12;63%),代理决策者以女性为主(n=13;68%)。
  • 研究在一所美国学术医疗中心进行。

研究设计与关键结果

  • 研究设计:一项大型前瞻性纵向队列研究(n=222)的一部分,采用建构主义扎根理论指导数据收集与分析。
  • 访谈对象:19例SABI患者的22名代理决策者,进行半结构化访谈。
  • 分析过程:经过多轮编码、访谈笔记、反思性备忘录和小组讨论,构建描述代理决策视角与预后不确定性体验之间关系的主题模型。
  • 两种决策视角:一组代理决策者感到明确的决策主体感;另一组报告更被动的角色,甚至不认为存在需要做的决定。
  • 两组代理决策者均将预后不确定性视为SABI的核心挑战,但应对方式不同。
  • 仅主动决策的代理决策者认为限时试验有帮助。

证据类型、等级与局限

  • 证据类型:质性研究(半结构化访谈),嵌套于前瞻性纵向队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需要针对代理决策者当前决策视角的纵向预后沟通策略。
  • 原文未据此给出其他推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: In the early phase of severe acute brain injury (SABI), surrogate decision-makers must make treatment decisions in the face of prognostic uncertainty. Evidence-based strategies to communicate uncertainty and support decision-making are lacking. Our objective was to better understand surrogate experiences and needs during the period of active decision-making in SABI, to inform interventions to support SABI patients and families and improve clinician-surrogate communication.

DESIGN: We interviewed surrogate decision-makers during patients' acute hospitalization for SABI, as part of a larger ( n = 222) prospective longitudinal cohort study of patients with SABI and their family members. Constructivist grounded theory informed data collection and analysis.

SETTING: One U.S. academic medical center.

PATIENTS: We iteratively collected and analyzed semistructured interviews with 22 surrogates for 19 patients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Through several rounds of coding, interview notes, reflexive memos, and group discussion, we developed a thematic model describing the relationship between surrogate perspectives on decision-making and surrogate experiences of prognostic uncertainty. Patients ranged from 20 to 79 years of age (mean = 55 years) and had primary diagnoses of stroke ( n = 13; 68%), traumatic brain injury ( n = 5; 26%), and anoxic brain injury after cardiac arrest ( n = 1; 5%). Patients were predominantly male ( n = 12; 63%), whereas surrogates were predominantly female ( n = 13; 68%). Two distinct perspectives on decision-making emerged: one group of surrogates felt a clear sense of agency around decision-making, whereas the other group reported a more passive role in decision-making, such that they did not even perceive there being a decision to make. Surrogates in both groups identified prognostic uncertainty as the central challenge in SABI, but they managed it differently. Only surrogates who felt they were actively deciding described time-limited trials as helpful.

CONCLUSIONS: In this qualitative study, not all surrogate "decision-makers" viewed themselves as making decisions. Nearly all struggled with prognostic uncertainty. Our findings underline the need for longitudinal prognostic communication strategies in SABI targeted at surrogates' current perspectives on decision-making.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Goss AL, Voumard RR, Engelberg RA, et al. Do They Have a Choice? Surrogate Decision-Making After Severe Acute Brain Injury. Crit Care Med. 2023. PMID: 36975213. doi:10.1097/CCM.0000000000005850

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。